- Home
- CELU vs PHUN Comparison
CELU vs PHUN Comparison
Compare CELU & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELU | PHUN |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 55.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CELU | PHUN |
|---|---|---|
| Price | $1.88 | $2.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $7.25 |
| AVG Volume (30 Days) | 62.5K | ★ 165.4K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,578,000.00 | $2,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | $73.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $1.83 |
| 52 Week High | $4.35 | $6.29 |
Technical Indicators
Market Signals| Indicator | CELU | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 42.88 |
| Support Level | $1.62 | $1.83 |
| Resistance Level | $2.01 | $2.13 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 48.80 | 72.22 |
Price Performance
Historical ComparisonAbout CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.